ππ» #bluesky GPCR
π Want to get to know me a bit better?
βοΈ Curious about what Iβve been working on?
I had a fun chatting on the Dr. GPCR #podcast to talk about my #journey, #research, and everything in between!
π₯ Watch on YouTube: lnkd.in/gzGQYX-x
π Podcast: lnkd.in/gbcGj_HH
#GPCR #compchem
05.08.2025 15:08 β π 5 π 2 π¬ 0 π 0
The Lipid Interactome Repository β Lipid Interactome Repository
We are proud to be a founding contributor to lipidinteractome.org, a repository developed by @tafesselab.bsky.social & Schultz lab to increase accessibility to proteomics data from multi-functionalized lipid analogs! Check out the website & preprint: arxiv.org/abs/2507.23101 #lipidtime
05.08.2025 13:06 β π 56 π 18 π¬ 1 π 1
Iβm really happy to share that Iβve passed my PhD viva in Computational Biochemistry! Itβs been an exciting journey and Iβm profoundly grateful to my supervisors Dr @marcvanderkamp.bsky.social and Dr Deborah Shoemark, and my collaborator Dr Richard Sessions for all their support and guidance.
25.07.2025 07:36 β π 6 π 1 π¬ 2 π 0
Once in a lifetime opportunity:
If youβre a bioRxiv screener and want to be the first to read
A Bayesian approach to interpret time-resolved experiments using molecular simulations
now is your chance π
22.07.2025 16:17 β π 18 π 3 π¬ 1 π 0
Applications for this position are closing tomorrow! Get yours in quickly π
19.07.2025 02:03 β π 2 π 2 π¬ 0 π 0
Complete collection of the COSB edition on New Concepts in Drug Discoverythat Rod Hubbard and I edited is now online. My deepest thanks to all authors for their excellent articles!
www.sciencedirect.com/special-issu...
16.07.2025 10:32 β π 8 π 3 π¬ 0 π 0
A stylized image of the molecular model of a mitochondrial crista, with proteins and lipids shown
What better way to use my first proper post than to share my first big piece of post-doctoral work with @cg-martini.bsky.social!
Here, we used integrative modelling to build and simulate a mitochondrial cristae.
Find the paper here (rdcu.be/eujAC) or see below for a quick overview π
01.07.2025 15:33 β π 45 π 14 π¬ 4 π 0
It was great to help out the lipids with these two Mycobacterial enzymes. Fantastic work from the Mancia lab!
08.07.2025 05:20 β π 9 π 3 π¬ 0 π 0
πWe proudly present our recent contribution to deciphering the #catalysis mechanism of π #F1-ATPase: Our model reconciles the decade-long bi-site vs. tri-site controversy, clarifying that both pathways contribute depending on #ATP concentration and more... #MarkovModel #Bayes @mpi-nat.bsky.social
08.07.2025 07:10 β π 4 π 2 π¬ 0 π 0
Very proud and honored to have recieved the SCALE-it Best PhD Award for Best Interdisciplinary Work! A great celebration, and a big thanks to @ihaenelt.bsky.social for her kind words and a fantastic time during my PhD!
04.07.2025 08:09 β π 9 π 1 π¬ 1 π 0
felicitations Directeur!
03.07.2025 07:23 β π 0 π 0 π¬ 1 π 0
This is now official: I got a CNRS "Directeur de Recherche" position!
I would like to thank all my collaborators and colleagues as well as the members of my team with whom I have the chance to do great science that was credited by this position. π
03.07.2025 05:09 β π 19 π 1 π¬ 3 π 0
Are you studying biophysical phenomena @interfaces ? Then check-out our newest toolbox doi.org/10.1016/j.bp..., featuring membranes and biopolymers (basic+advanced) analyses in 2D! π« π π¦ π§¬π§Ά πͺ’Awesome Collab with @vmonje.bsky.social 's group! Video intro HERE!
30.06.2025 14:08 β π 7 π 3 π¬ 0 π 0
π§ͺ New preprint: "Generative Modeling of Full-Atom Protein Conformations using Latent Diffusion on Graph Embeddings"
We generate complete, all-atom protein conformational ensembles, capturing both backbone and side-chain dynamics of, e.g., the Dopamine D2 receptor.
arxiv.org/abs/2506.17064
26.06.2025 09:53 β π 11 π 4 π¬ 1 π 1
"Writing a peer review, then, or even going from initial notes to the final text, requires capacities that an LLM simply lacks: our unique perspective, training, values, ethics, domain expertise, understanding of editorial priorities and perceptions of the authors" ππ»ππ»ππ»β¬οΈ
25.06.2025 20:11 β π 11 π 4 π¬ 0 π 0
Insights into the Enhanced Ceftazidime Hydrolysis by Ent385 AmpC Ξ²-Lactamase from Multiscale Simulations
The emergence of multidrug-resistant bacteria poses a significant threat to public health. Particularly, they are becoming increasingly resistant to Ξ²-lactam antibiotics, which are one of the most important drug classes for the treatment of bacterial infections. Ceftazidime-avibactam has shown promising activity against highly drug-resistant bacteria, including carbapenem-resistant Enterobacterales. However, an Ala294-Pro295 deletion in the Class CE. cloacaeAmpC Ξ²-lactamase can confer reduced susceptibility to these agents. In this study, we investigated the molecular mechanisms underlying the enhanced hydrolysis of ceftazidime by E. cloacae Ent385 AmpC Ξ²-lactamase with the deletion using quantum mechanics/molecular mechanics (QM/MM) simulations. We used constant pH molecular dynamics simulations of the Ξ²-lactamase-ceftazidime acyl-enzyme complex to verify the likely protonation states, confirming Tyr150 primarily exists as a tyrosinate. We then used QM/MM (DFTB2/ff14SB) umbrella sampling to calculate the reaction-free energy barriers (Ξβ‘G) for the deacylation step of cephalosporin hydrolysis. This reveals that Tyr150 (rather than the substrate) acts as the base. Importantly, the difference in Ξβ‘G between the canonical E. cloacae AmpC (P99) and the Ent385 variant with Ala294-Pro295 reinserted, on the one hand, and the Ent385 variant, on the other, was in very good agreement with the difference deduced from experimental kinetic data. Detailed analysis of the transition state ensembles, alongside additional simulations, shows that the Ala294-Pro295 deletion allows the entrance of an additional water molecule that helps stabilize the tetrahedral intermediate. Overall, our QM/MM simulations provide valuable insights into the reaction mechanism and reasons for enhanced ceftazidime breakdown. The protocol used in this study successfully captures the kinetic differences observed among the studied variants. This approach can be employed to investigate other Class C Ξ²-lactamase variants with similar features, providing insights into their mechanisms and potential contributions to reduced susceptibility to antibiotic treatments.
Our first foray into Class C beta-lactamases - explaining how #antibiotic ceftazidime is broken down more easily by AmpC variants.
#AMR
#enzymes
#compchem
Great work by @andersonlimaaa.bsky.social, as @royalsociety.org fellow
ACS Catalysis (Open Access): pubs.acs.org/doi/10.1021/...
23.06.2025 13:44 β π 10 π 4 π¬ 1 π 0
FΓ©licitations Matthieu!
18.06.2025 07:40 β π 0 π 0 π¬ 1 π 0
I have defended yesterday my HDR. I would like to especially thank the members of my jury: CΓ©cile Albenne, CΓ©lia PLISSON, Juan CortΓ©s, @nathaliereuter.bsky.social , SΓ©bastien Fiorucci , and Patrick Fuchs ! It was a wonderful moment of discussions about science and also beyond!
18.06.2025 07:22 β π 25 π 2 π¬ 4 π 1
Great collab with @robincorey.bsky.social & @pstansfeld.bsky.social! Thanks Wei-Chuen Poh for some help too! Do take a look and give us some comments! #MicroSky #SGBUG
www.biorxiv.org/content/10.1...
17.06.2025 11:02 β π 3 π 1 π¬ 0 π 0
Super excited to share our latest work revealing impt of protein-lipid interactions for the pri fn of the Tol-Pal complex in maintaining outer memb lipid homeostasis in E. coli! Huge discovery by Nadege Lim in collab @pstansfeld.bsky.social @robincorey.bsky.social 1/7
www.biorxiv.org/content/10.1...
17.06.2025 11:02 β π 18 π 12 π¬ 1 π 0
Image shows the front page of the paper listing author names, journal title and the abstract. The link will take you to the same page
New paper π¨super proud of this collaborative effort, and grateful to my co-authors for answering the reviewer comments whilst I was on mat leave. You can find it here pubs.rsc.org/en/content/a...
16.06.2025 17:07 β π 1 π 1 π¬ 0 π 0
Programme β GPCR-UK
Excited to present my work at the Inaugural GPCR-UK Network Meeting this September in Cambridge: gpcr-uk.org/programme/. Thank you to the organizers for putting together such a fantastic programme! Looking forward to meeting new GPCR enthusiasts and connecting with UK-based investigators. π¬π§
16.06.2025 17:15 β π 3 π 3 π¬ 0 π 0
It is online since a few days, so time to recap: Our first steps in a new field of bacterial polysaccharide secretion, focused on Pel system from Pseudomonas aeruginosa:
www.nature.com/articles/s41...
15.06.2025 08:41 β π 50 π 15 π¬ 4 π 1
Excited to unveil Boltz-2, our new model capable not only of predicting structures but also binding affinities! Boltz-2 is the first AI model to approach the performance of FEP simulations while being more than 1000x faster! All open-sourced under MIT license! A threadβ¦ π€π
06.06.2025 13:46 β π 215 π 92 π¬ 9 π 10
Fixing the Flaws in AlphaFoldβs Interface Scoring: Meet Dunbrackβs ipSAE
Predicting protein-protein interactions Since AlphaFold2 was published, one of the major applications of the model was accurately predicting the structure of protein-protein interactions. By taking as...
As @rolanddunbrack.bsky.social recently discovered, one of the issues with the ipTM score used AF2 to represent the ipTM score is that it is biased by disordered regions of the protein outside the binding interface. To address this, he implemented a new metric, ipSAE.
levitate.bio/alphafold/mu...
03.06.2025 14:10 β π 11 π 4 π¬ 4 π 1
Associate Professor at University of Birmingham, UK. Study lipids, membranes, and how cells respond to the lack of oxygen
βͺPostdoc @ FCEN UBA w/βͺ @diegulise.bsky.socialβ¬
& moving soon toβͺβͺ @crg.euβ¬ w/M. Dias and @jonnyfrazer.bsky.social
> Biological Physics | Proteins | Comp Bio | ML
https://scholar.google.com/citations?user=n55NtEsAAAAJ&hl=en
BHF Intermediate Basic Science Research Fellow, University of Bristol,
Lab Homepage: https://paul-lab-site.github.io/
Top 10 UK Uni π Leading research π¬ World-class teaching π©βπ Vibrant city π Ranked 51st in the π (World University Rankings 2026) #WeAreBristolUni
bristol.ac.uk
Physicist and engineer, into multiple scale models of proteins/RNA/membranes, polymers, scientific computing, more --> http://tinyurl.com/goCompModeling
PhD student, Neuroscience, CSIR Fellow, Investigating Alzheimer's disease crosstalk with metabolic syndrome | Using Bioinformatics, Machine Learning and AI in research.
#Braindisease #Drugdiscovery #Academia
PhD student @MIT β’ Research on Generative Models for Biophysics and Drug Discovery
I'm a pharmaceutical chemist working at the interface of cheminformatics, molecular modeling, and machine learning. All views are my own.
https://ligandintheloop.blogspot.com/
Plant scientist π±π¦ π§« π²π½ | Postdoc at the University of Zurich in the Cyril Zipfel and Pedro Beltrao groups, studying protein phosphorylation during plantβmicrobe interactions #EMBOfellow | @thesainsburylab.bsky.social alumni
PhD Candidate @ Lehigh University
Senior scientist at #CNRS, #ENS.
#Biophysics. Physical Chemistry for #LifeScience. #Organelles. #RNA #condensate
PhD student at IISER Bhopal. Membrane protein folding. Currently looking for a postdoc position.
PhD student in MPI for multidisciplinary sciences, GΓΆttingen
PhD in Computational Chemistry | πParis | π‘Istanbul
Computational chemist, process design engineer, consultant
https://www.linkedin.com/in/andyonlinkedin/
πΊπ¦ Computational biophysicist, multitasker, and beer lover. PI @ Masaryk University.
Professor of Biochemistry
Research interest: membrane biochemistry with focus on ABC transporters, drug efflux systems, bacterial secretion system, lantibiotics, and deubiquitinases
https://www.biochemistry1.hhu.de
Molecular & Membrane Biophysics
Dept. of Biochem. & Mol. Biol.
Carver College of Medicine
https://bmb.medicine.uiowa.edu/profile/venkata-mandala
https://scholar.google.com/citations?user=2fTrEY4AAAAJ&hl=en
Postdoc at UCSF in Weiner Lab (@oweinerlab.bsky.social)
PhD UC Berkeley in Park Lab
(she/her)
UCSD, HHMI
Neuroscience, protein design, climate change